Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study
Background: Hyperlipidemia is modifiable risk factor for cardiovascular diseases, and its prevalence is alarmingly increasing in India. Though different treatment modalities are effectively used in the conventional system, they have certain limitations including certain adverse effects. Ayurvedic me...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
| Series: | Indian Journal of Ayurveda and Integrative Medicine KLEU |
| Subjects: | |
| Online Access: | http://www.ijaim.in/article.asp?issn=2772-6010;year=2019;volume=1;issue=1;spage=4;epage=10;aulast=Swapnil |
| _version_ | 1797866665291022336 |
|---|---|
| author | Chaudhari Swapnil R Galib B J Patgiri P K Prajapati |
| author_facet | Chaudhari Swapnil R Galib B J Patgiri P K Prajapati |
| author_sort | Chaudhari Swapnil |
| collection | DOAJ |
| description | Background: Hyperlipidemia is modifiable risk factor for cardiovascular diseases, and its prevalence is alarmingly increasing in India. Though different treatment modalities are effectively used in the conventional system, they have certain limitations including certain adverse effects. Ayurvedic metallic and herbo-mineral formulations are safely practiced in Indian subcontinent without any evident side effects. Hridayarnava Rasa is one such Ayurvedic herbo-metalo-mineral formulation containing Tamra Bhasma (incinerated copper) that is being successfully prescribed in the management of lipid disorders.
Aims and Objectives: To evaluate antihyperlipidemic effect of two samples of Hridayarnava Rasa prepared by using Tamra Bhasma processed in Surana Kanda (HRTBS) and Panchamrita during Amritikarana (HRTBP).
Materials and methods: Total 126 patients of hyperlipidemia fulfilling inclusion criteria were randomly grouped into two. Patients registered in one group (n = 62) were administered with 125 mg of HRTBP (Hridayarnava Rasa prepared by using Tamra Bhasma processed in Panchamrita for Amritikarana) and another Group (n =64) with HRTBS (Hridayarnava Rasa prepared by using Tamra Bhasma processed in Suranakanda for Amritikarana) twice daily for 8 weeks along with honey as an adjuvant in both groups.
Results and Conclusion: Both the drugs have shown significant effect in reducing lipid parameters but the difference in between the groups is statistically insignificant. On comparison, HRTBP showed better results than HRTBS. |
| first_indexed | 2024-04-09T23:28:58Z |
| format | Article |
| id | doaj.art-cd57e7b3b7b34856aa34bdb9d708e5d9 |
| institution | Directory Open Access Journal |
| issn | 2772-6010 2772-6029 |
| language | English |
| last_indexed | 2024-04-09T23:28:58Z |
| publishDate | 2019-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Ayurveda and Integrative Medicine KLEU |
| spelling | doaj.art-cd57e7b3b7b34856aa34bdb9d708e5d92023-03-21T07:35:06ZengWolters Kluwer Medknow PublicationsIndian Journal of Ayurveda and Integrative Medicine KLEU2772-60102772-60292019-01-0111410Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical studyChaudhari SwapnilR GalibB J PatgiriP K PrajapatiBackground: Hyperlipidemia is modifiable risk factor for cardiovascular diseases, and its prevalence is alarmingly increasing in India. Though different treatment modalities are effectively used in the conventional system, they have certain limitations including certain adverse effects. Ayurvedic metallic and herbo-mineral formulations are safely practiced in Indian subcontinent without any evident side effects. Hridayarnava Rasa is one such Ayurvedic herbo-metalo-mineral formulation containing Tamra Bhasma (incinerated copper) that is being successfully prescribed in the management of lipid disorders. Aims and Objectives: To evaluate antihyperlipidemic effect of two samples of Hridayarnava Rasa prepared by using Tamra Bhasma processed in Surana Kanda (HRTBS) and Panchamrita during Amritikarana (HRTBP). Materials and methods: Total 126 patients of hyperlipidemia fulfilling inclusion criteria were randomly grouped into two. Patients registered in one group (n = 62) were administered with 125 mg of HRTBP (Hridayarnava Rasa prepared by using Tamra Bhasma processed in Panchamrita for Amritikarana) and another Group (n =64) with HRTBS (Hridayarnava Rasa prepared by using Tamra Bhasma processed in Suranakanda for Amritikarana) twice daily for 8 weeks along with honey as an adjuvant in both groups. Results and Conclusion: Both the drugs have shown significant effect in reducing lipid parameters but the difference in between the groups is statistically insignificant. On comparison, HRTBP showed better results than HRTBS.http://www.ijaim.in/article.asp?issn=2772-6010;year=2019;volume=1;issue=1;spage=4;epage=10;aulast=Swapnilcopperhridayarnava rasahyperlipidemiatamra |
| spellingShingle | Chaudhari Swapnil R Galib B J Patgiri P K Prajapati Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study Indian Journal of Ayurveda and Integrative Medicine KLEU copper hridayarnava rasa hyperlipidemia tamra |
| title | Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study |
| title_full | Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study |
| title_fullStr | Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study |
| title_full_unstemmed | Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study |
| title_short | Anti-hyperlipidemic effect of Hridayarnava Rasa - A randomized double blind clinical study |
| title_sort | anti hyperlipidemic effect of hridayarnava rasa a randomized double blind clinical study |
| topic | copper hridayarnava rasa hyperlipidemia tamra |
| url | http://www.ijaim.in/article.asp?issn=2772-6010;year=2019;volume=1;issue=1;spage=4;epage=10;aulast=Swapnil |
| work_keys_str_mv | AT chaudhariswapnil antihyperlipidemiceffectofhridayarnavarasaarandomizeddoubleblindclinicalstudy AT rgalib antihyperlipidemiceffectofhridayarnavarasaarandomizeddoubleblindclinicalstudy AT bjpatgiri antihyperlipidemiceffectofhridayarnavarasaarandomizeddoubleblindclinicalstudy AT pkprajapati antihyperlipidemiceffectofhridayarnavarasaarandomizeddoubleblindclinicalstudy |